Moderna Inc (NASDAQ:MRNA) shares traded higher Thursday after the company reported better-than-expected earnings per share and sales results.

The company reported earnings per share of $6.46, beating the $6.04 estimate. Sales results came in at $4.4 billion, beating the estimate of $4.28 billion.

Moderna shares were trading even at $416.07 at last check Thursday.

See Also: Moderna Sold Less Than Expected mRNA COVID-19 Vaccine Jabs In Q2; Sees $20B In FY21 Product Sales

Moderna Daily Chart Analysis

What’s Next For Moderna?

Bullish traders are looking to see the stock continue to form higher lows and climb higher. Bulls want the stock to see stock continue to trade above the higher low trendline.

Bearish traders would like to see the stock begin to cool off and start falling toward the higher low trendline. Bears would then like to have the stock cross below the trendline for a possible change of trend.